| Upcoming events on ASTELLAS PHARMA INC. |
|
| 01/29/21 | | Q3 2020 Pubblicazione dei risultati |
| 01/29/21 | 08:00am | | Q3 2020 Presentazione dei risultati |
| 03/30/21 | | Desprendimiento de dividendo final |
| 07/23/21 | | Q1 2021 Pubblicazione dei risultati (proiezione) |
|
| Past events on ASTELLAS PHARMA INC. |
|
| 12/10/20 | 05:00am | | R&D Day |
| 12/06/20 | 07:30pm | | American Society of Hematology Meeting - Abstract #334 |
| 12/06/20 | 07:15pm | | American Society of Hematology Meeting - Abstract 333 |
| 12/05/20 | 09:00pm | | American Society of Hematology Meeting - Abstract #213 |
|
| Upcoming sector events for ASTELLAS PHARMA INC. |
|
|
| |
|
| Past sector events for ASTELLAS PHARMA INC. |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M JPY |
Released
Forecast
Spread | 1 372 706
1 389 912
-1,2% | 1 311 665
1 319 255
-0,58% | 1 300 316
1 295 193
0,40% | 1 306 348
1 300 930
0,42% | 1 300 843
1 274 827
2,0% |
1 269 281
|
Operating income
(EBITDA)
M JPY |
Released
Forecast
Spread | 337 887
313 439
7,8% | 324 621
331 297
-2,0% | 278 121
287 331
-3,2% | 307 370
320 763
-4,2% | 310 387
316 993
-2,1% |
304 771
|
Operating profit
(EBIT)
M JPY |
Released
Forecast
Spread | 268 699
241 562
11% | 260 830
271 929
-4,1% | 213 258
228 416
-6,6% | 243 912
261 093
-6,6% | 243 991
257 148
-5,1% |
231 884
|
Pre-Tax Profit
(EBT)
M JPY |
Released
Forecast
Spread | 261 770
252 112
3,8% | 281 769
278 738
1,1% | 218 113
230 652
-5,4% | 248 967
259 605
-4,1% | 245 350
262 926
-6,7% |
230 198
|
Net income
M JPY |
Released
Forecast
Spread | 193 687
180 479
7,3% | 218 701
205 634
6,4% | 164 679
178 600
-7,8% | 222 265
215 115
3,3% | 195 411
203 519
-4,0% |
184 530
|
EPS
JPY |
Released
Forecast
Spread | 89,8
83,4
7,7% | 104
97,9
5,9% | 81,1
89,5
-9,4% | 115
113
1,6% | 104
113
-7,8% |
101
| | Announcement Date | 05/11/2016 | 04/27/2017 | 04/26/2018 | 04/25/2019 | 05/14/2020 | |
|
|
|
| Quarterly results | 2016 S2 | 2017 S1 | 2018 S1 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) | 2022 S1 (e) | 2023 S1 (e) |
Sales
M |
Released
Forecast
Spread | 685 205
| 651 673
655 500
-0,58% | 639 754
633 500
0,99% | 660 562
653 200
1,1% | 329 085
318 313
3,4% | 318 011
326 974
-2,7% | 647 096
646 500
0,09% | 357 900
359 208
-0,36% | 301 320
311 288
-3,2% |
| 334 134
313 367
6,6% | 316 336
300 622
5,2% | 650 470
630 717
3,1% | 338 065
327 167
3,3% | 312 308
293 033
6,6% | 306 969
313 838
-2,2% | 308 511
317 330
-2,8% | 615 480
631 150
-2,5% |
327 175
|
320 285
|
314 000
|
631 000
|
643 000
|
Operating income
(EBITDA)
M |
Released
Forecast
Spread |
| 198 738
| 128 290
|
| 79 628
78 775
1,1% | 79 059
86 968
-9,1% |
| 98 400
98 767
-0,37% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M JPY |
Released
Forecast
Spread |
| 157 057
163 000
-3,6% | 96 077
112 000
-14% | 117 181
109 250
7,3% | 63 548
65 717
-3,3% | 63 294
72 171
-12% | 126 842
131 500
-3,5% | 82 500
69 718
18% | 34 541
54 839
-37% |
| 77 086
67 500
14% | 85 110
60 293
41% | 162 196
135 036
20% | 75 462
64 475
17% | 6 333
35 700
-82% | 60 815
72 233
-16% | 26 057
69 070
-62% | 86 872
139 408
-38% |
72 300
|
56 800
|
66 000
|
130 500
|
131 000
|
Pre-Tax Profit
(EBT)
M JPY |
Released
Forecast
Spread |
| 157 772
164 500
-4,1% | 101 224
119 400
-15% | 116 889
109 300
6,9% | 64 495
66 163
-2,5% | 63 803
72 509
-12% | 128 298
| 84 500
69 909
21% | 36 139
55 100
-34% |
| 76 528
68 000
13% | 85 056
60 593
40% | 161 584
134 807
20% | 77 601
64 575
20% | 6 165
39 200
-84% | 60 238
72 033
-16% | 28 853
69 236
-58% | 89 091
139 808
-36% |
72 300
|
56 800
|
65 500
|
131 200
|
132 000
|
Net income
M JPY |
Released
Forecast
Spread |
| 115 064
120 900
-4,8% | 82 117
92 400
-11% | 82 562
80 100
3,1% | 54 559
52 875
3,2% | 49 308
56 064
-12% | 103 867
106 000
-2,0% | 87 700
53 084
65% | 30 730
43 529
-29% |
| 58 518
53 533
9,3% | 70 009
47 593
47% | 128 527
105 652
22% | 61 494
52 900
16% | 5 390
30 600
-82% | 50 413
56 367
-11% | 22 425
54 652
-59% | 72 838
110 808
-34% |
56 400
|
44 300
|
52 000
|
104 200
|
105 000
|
EPS
|
Released
Forecast
Spread |
| 54,2
57,9
-6,5% | 40,0
45,8
-13% | 41,1
38,4
7,1% | 27,7
27,7
0,03% | 25,5
28,9
-12% | 53,2
51,1
4,1% | 45,4
29,9
52% | 16,4
22,7
-28% | 61,9
| 31,0
27,2
14% | 37,1
29,7
25% | 68,2
57,4
19% | 32,8
29,3
12% | 3,19
15,6
-80% | 27,1
29,3
-7,4% | 12,1
27,3
-56% | 39,2
54,5
-28% |
30,1
|
24,7
|
28,4
|
56,9
|
58,1
| | Announcement Date | 05/11/2016 | 10/28/2016 | 10/31/2017 | 04/26/2018 | 07/27/2018 | 10/31/2018 | 10/31/2018 | 01/31/2019 | 04/25/2019 | 04/25/2019 | 07/30/2019 | 10/31/2019 | 10/31/2019 | 01/31/2020 | 05/14/2020 | 08/04/2020 | 10/30/2020 | 10/30/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
